NASDAQ:IRIX - IRIDEX Stock Price, Price Target & More

$5.59 -0.11 (-1.93 %)
(As of 04/26/2018 09:36 AM ET)
Previous Close$5.70
Today's Range$5.59 - $5.92
52-Week Range$5.31 - $12.43
Volume35,200 shs
Average Volume22,876 shs
Market Capitalization$66.28 million
P/E Ratio-5.04
Dividend YieldN/A
Beta1.4

About IRIDEX (NASDAQ:IRIX)

IRIDEX logoIRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. The company offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser systems, which are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. It also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; and slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures. In addition, the company offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system that delivers laser to treat glaucoma; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe Illuminate and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products used in vitrectomy procedures. It serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. IRIDEX Corporation markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was founded in 1989 and is headquartered in Mountain View, California.

Receive IRIX News and Ratings via Email

Sign-up to receive the latest news and ratings for IRIX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorComputer and Technology
SymbolNASDAQ:IRIX
CUSIPN/A
Phone650-940-4700

Debt

Debt-to-Equity RatioN/A
Current Ratio3.80%
Quick Ratio2.89%

Price-To-Earnings

Trailing P/E Ratio-5.04
Forward P/E Ratio-4.90
P/E GrowthN/A

Sales & Book Value

Annual Sales$41.59 million
Price / Sales1.56
Cash FlowN/A
Price / CashN/A
Book Value$2.64 per share
Price / Book2.12

Profitability

EPS (Most Recent Fiscal Year)($1.11)
Net Income$-12,860,000.00
Net Margins-30.93%
Return on Equity-35.98%
Return on Assets-28.84%

Miscellaneous

Employees116
Outstanding Shares11,630,000

How to Become a New Pot Stock Millionaire

IRIDEX (NASDAQ:IRIX) Frequently Asked Questions

What is IRIDEX's stock symbol?

IRIDEX trades on the NASDAQ under the ticker symbol "IRIX."

How were IRIDEX's earnings last quarter?

IRIDEX Co. (NASDAQ:IRIX) posted its quarterly earnings data on Thursday, March, 8th. The medical equipment provider reported ($0.44) EPS for the quarter, missing the Zacks' consensus estimate of ($0.27) by $0.17. The medical equipment provider had revenue of $10.24 million for the quarter, compared to the consensus estimate of $10.22 million. IRIDEX had a negative return on equity of 35.98% and a negative net margin of 30.93%. View IRIDEX's Earnings History.

When is IRIDEX's next earnings date?

IRIDEX is scheduled to release their next quarterly earnings announcement on Thursday, May, 3rd 2018. View Earnings Estimates for IRIDEX.

What price target have analysts set for IRIX?

1 brokers have issued 1-year price targets for IRIDEX's shares. Their predictions range from $13.00 to $13.00. On average, they expect IRIDEX's stock price to reach $13.00 in the next year. View Analyst Ratings for IRIDEX.

Who are some of IRIDEX's key competitors?

Who are IRIDEX's key executives?

IRIDEX's management team includes the folowing people:
  • Mr. William M. Moore, Chairman, Chief Exec. Officer and Pres (Age 69)
  • Mr. Atabak Mokari, Chief Financial Officer and VP of Corp. Devel. (Age 41)
  • Dr. George R. Marcellino Ph.D., VP of Clinical Affairs & Director (Age 69)
  • Mr. Timothy D. Buckley, VP of Global Marketing & Bus. Devel. (Age 43)
  • Ms. Stacie Rodgers, VP of HR

Has IRIDEX been receiving favorable news coverage?

News coverage about IRIX stock has trended somewhat positive on Thursday, according to Accern Sentiment Analysis. The research firm identifies negative and positive press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. IRIDEX earned a news sentiment score of 0.15 on Accern's scale. They also gave press coverage about the medical equipment provider an impact score of 45.34 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

How do I buy shares of IRIDEX?

Shares of IRIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is IRIDEX's stock price today?

One share of IRIX stock can currently be purchased for approximately $5.59.

How big of a company is IRIDEX?

IRIDEX has a market capitalization of $66.28 million and generates $41.59 million in revenue each year. The medical equipment provider earns $-12,860,000.00 in net income (profit) each year or ($1.11) on an earnings per share basis. IRIDEX employs 116 workers across the globe.

How can I contact IRIDEX?

IRIDEX's mailing address is 1212 Terra Bella Avenue, Mountain View CA, 94043. The medical equipment provider can be reached via phone at 650-940-4700 or via email at [email protected]


MarketBeat Community Rating for IRIDEX (IRIX)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  102 (Vote Outperform)
Underperform Votes:  99 (Vote Underperform)
Total Votes:  201
MarketBeat's community ratings are surveys of what our community members think about IRIDEX and other stocks. Vote "Outperform" if you believe IRIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IRIX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

IRIDEX (NASDAQ:IRIX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for IRIDEX in the last 12 months. Their average twelve-month price target is $13.00, suggesting that the stock has a possible upside of 132.56%. The high price target for IRIX is $13.00 and the low price target for IRIX is $13.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $13.00$13.00$13.00$20.00
Price Target Upside: 132.56% upside52.22% upside52.22% upside51.29% upside

IRIDEX (NASDAQ:IRIX) Consensus Price Target History

Price Target History for IRIDEX (NASDAQ:IRIX)

IRIDEX (NASDAQ:IRIX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/3/2017Roth CapitalReiterated RatingBuy -> Buy$13.00N/AView Rating Details
(Data available from 4/26/2016 forward)

Earnings

IRIDEX (NASDAQ:IRIX) Earnings History and Estimates Chart

Earnings by Quarter for IRIDEX (NASDAQ:IRIX)

IRIDEX (NASDAQ:IRIX) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.14 EPS
Next Year EPS Consensus Estimate: $-0.59 EPS

IRIDEX (NASDAQ IRIX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/3/2018($0.33)N/AView Earnings Details
3/8/2018Q4 2017($0.27)($0.44)$10.22 million$10.24 millionViewN/AView Earnings Details
11/2/2017Q3 2017($0.27)$10.87 millionViewN/AView Earnings Details
8/3/2017Q2 2017($0.18)($0.2380)$10.48 million$10.00 millionViewListenView Earnings Details
5/3/2017Q1 2017($0.18)($0.1620)$10.62 million$10.48 millionViewListenView Earnings Details
3/8/2017Q4 2016($0.03)($0.11)$12.54 million$12.53 millionViewN/AView Earnings Details
11/3/2016Q316($0.03)($0.07)$11.20 million$9.79 millionViewListenView Earnings Details
8/4/2016Q216$0.01($0.03)$11.90 million$11.90 millionViewListenView Earnings Details
5/5/2016Q116$0.04$0.01$11.88 million$11.90 millionViewListenView Earnings Details
3/3/2016Q415$0.04$0.04$11.80 million$12.10 millionViewListenView Earnings Details
11/5/2015Q315$0.04$10.10 million$9.80 millionViewListenView Earnings Details
8/6/2015Q215($0.07)$10.60 million$9.00 millionViewListenView Earnings Details
5/7/2015Q115$0.02$10.30 million$10.80 millionViewListenView Earnings Details
3/5/2015Q4 2014$0.86$11.78 millionViewN/AView Earnings Details
10/30/2014Q3 2014$0.05$10.12 millionViewN/AView Earnings Details
7/31/2014Q2 2014$0.03$10.59 millionViewN/AView Earnings Details
5/1/2014Q1$0.06$0.05$8.90 million$10.30 millionViewListenView Earnings Details
2/27/2014Q4$0.04$0.04$10.60 millionViewListenView Earnings Details
10/31/2013Q3 2013$0.04$0.05$9.53 millionViewN/AView Earnings Details
8/1/2013Q2 2013$0.04$0.04$9.21 millionViewN/AView Earnings Details
5/2/2013Q1 2013$0.09$8.94 millionViewN/AView Earnings Details
2/28/2013Q4 2012$0.03ViewN/AView Earnings Details
11/1/2012Q3 2012($0.06)ViewN/AView Earnings Details
8/2/2012Q2 2012$0.04ViewN/AView Earnings Details
5/3/2012Q1 2012($0.03)ViewN/AView Earnings Details
11/3/2011Q3 2011$0.03ViewN/AView Earnings Details
8/4/2011Q2 2011$0.09ViewN/AView Earnings Details
5/5/2011Q1 2011$0.06ViewN/AView Earnings Details
3/3/2011Q4 2010$0.08ViewN/AView Earnings Details
11/4/2010Q3 2010$0.09ViewN/AView Earnings Details
8/5/2010Q2 2010$0.08ViewN/AView Earnings Details
5/6/2010Q1 2010$0.06ViewN/AView Earnings Details
3/4/2010Q4 2009$0.06ViewN/AView Earnings Details
11/12/2009Q3 2009$0.07ViewN/AView Earnings Details
8/13/2009Q2 2009$0.13ViewN/AView Earnings Details
5/14/2009Q1 2009$0.03ViewN/AView Earnings Details
3/10/2009Q4 2008($0.13)ViewN/AView Earnings Details
11/4/2008Q3 2008($0.03)ViewN/AView Earnings Details
8/12/2008Q2 2008$0.03ViewN/AView Earnings Details
5/13/2008Q1 2008($0.10)ViewN/AView Earnings Details
4/10/2008Q4 2007($0.72)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

IRIDEX (NASDAQ:IRIX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

IRIDEX (NASDAQ IRIX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 5.01%
Institutional Ownership Percentage: 48.23%
Insider Trading History for IRIDEX (NASDAQ:IRIX)
Institutional Ownership by Quarter for IRIDEX (NASDAQ:IRIX)

IRIDEX (NASDAQ IRIX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/13/2018Romeo R DizonInsiderSell2,806$5.86$16,443.16View SEC Filing  
12/12/2017William M MooreCEOBuy5,000$7.84$39,200.00View SEC Filing  
9/15/2017William M MooreChairmanBuy1,800$9.42$16,956.00372,434View SEC Filing  
3/15/2017Romeo R DizonInsiderSell2,811$13.16$36,992.7617,289View SEC Filing  
11/16/2016Romeo R DizonInsiderSell584$16.04$9,367.3620,434View SEC Filing  
9/12/2016Romeo R DizonInsiderSell125$15.00$1,875.0020,163View SEC Filing  
9/7/2016Ruediger Naumann-EtienneDirectorSell9,513$14.75$140,316.7571,433View SEC Filing  
9/2/2016Ruediger Naumann-EtienneDirectorSell2,513$14.73$37,016.4971,433View SEC Filing  
8/23/2016Romeo R DizonInsiderSell875$14.52$12,705.0020,975View SEC Filing  
8/19/2016Romeo R DizonInsiderSell7,896$13.52$106,753.9220,123View SEC Filing  
8/16/2016George R MarcellinoDirectorSell2,513$13.57$34,101.411,289View SEC Filing  
8/16/2016Romeo R DizonInsiderSell839$13.70$11,494.3020,100View SEC Filing  
6/6/2016Ronald SteckelVPSell625$13.52$8,450.0066,250View SEC Filing  
5/17/2016Ronald SteckelVPSell4,583$12.81$58,708.2368,958View SEC Filing  
3/8/2016Ronald SteckelVPSell12,000$10.45$125,400.0075,125View SEC Filing  
11/19/2015William M MooreCEOBuy10,000$9.83$98,300.00290,931View SEC Filing  
9/25/2015Associates & Paragon A ParagonMajor ShareholderBuy52,042$7.05$366,896.10View SEC Filing  
9/10/2015Associates & Paragon A ParagonMajor ShareholderBuy11,866$6.95$82,468.70View SEC Filing  
9/4/2015Associates & Paragon A ParagonMajor ShareholderBuy10,304$6.81$70,170.24View SEC Filing  
9/2/2015Ronald SteckelVPSell1,875$6.80$12,750.0028,875View SEC Filing  
8/21/2015Associates & Paragon A ParagonMajor ShareholderBuy20,651$7.16$147,861.16View SEC Filing  
8/19/2015James H. MackanessCFOSell2,373$7.15$16,966.9545,052View SEC Filing  
8/19/2015Ronald SteckelVPSell1,751$7.14$12,502.1428,875View SEC Filing  
8/18/2015James H. MackanessCFOSell2,627$7.10$18,651.7044,558View SEC Filing  
8/17/2015James H. MackanessCFOSell2,235$7.05$15,756.7544,558View SEC Filing  
8/14/2015James H MackanessCFOSell7,765$6.99$54,277.35View SEC Filing  
8/14/2015Ronald SteckelVPSell1,458$7.00$10,206.00View SEC Filing  
7/24/2015Associates & Paragon A ParagonMajor ShareholderBuy40,403$7.01$283,225.03View SEC Filing  
6/17/2015Ronald SteckelVPSell1,666$8.77$14,610.82View SEC Filing  
5/20/2015James H MackanessCFOSell2,000$9.80$19,600.00View SEC Filing  
5/18/2015Ronald SteckelVPSell1,667$9.33$15,553.11View SEC Filing  
4/20/2015Ronald SteckelVPSell1,447$9.79$14,166.13View SEC Filing  
4/17/2015Ronald SteckelVPSell1,667$9.86$16,436.62View SEC Filing  
3/17/2015Ronald SteckelVPSell11,358$10.08$114,488.64View SEC Filing  
3/10/2015Ronald SteckelVPSell1,250$10.03$12,537.50View SEC Filing  
2/17/2015Ronald SteckelVPSell1,650$9.79$16,153.50View SEC Filing  
1/20/2015Ronald SteckelVPSell1,650$9.03$14,899.50View SEC Filing  
12/17/2014Ronald SteckelVPSell1,650$8.52$14,058.00View SEC Filing  
11/17/2014Ronald SteckelVPSell1,650$8.28$13,662.00View SEC Filing  
11/6/2014William M MooreDirectorBuy5,000$7.79$38,950.00View SEC Filing  
10/12/2014Catalyst Fund Ix L.P BluelineDirectorBuy17,237$8.11$139,792.07View SEC Filing  
10/10/2014Catalyst Fund Ix L.P BluelineDirectorBuy12,798$8.02$102,639.96View SEC Filing  
9/5/2014Catalyst Fund Ix L.P BluelineDirectorBuy8,432$7.99$67,371.68View SEC Filing  
8/29/2014Catalyst Fund Ix L.P BluelineDirectorBuy4,272$7.92$33,834.24View SEC Filing  
8/22/2014James B HawkinsDirectorSell600$8.03$4,818.00View SEC Filing  
8/18/2014Ronald SteckelVPSell1,650$8.00$13,200.00View SEC Filing  
8/15/2014James B HawkinsDirectorSell14,400$8.10$116,640.00View SEC Filing  
8/14/2014James B HawkinsDirectorSell2,714$8.08$21,929.12View SEC Filing  
8/13/2014James B HawkinsDirectorSell9,786$8.11$79,364.46View SEC Filing  
8/11/2014Garrett A GarrettsonDirectorSell2,810$8.30$23,323.00View SEC Filing  
7/31/2014Ronald SteckelVPSell761$8.00$6,088.00View SEC Filing  
7/21/2014James H MackanessCFOSell1,000$7.62$7,620.00View SEC Filing  
6/23/2014James H MackanessCFOSell2,000$8.24$16,480.00View SEC Filing  
6/17/2014Ronald SteckelVPSell1,650$8.20$13,530.00View SEC Filing  
6/6/2014Catalyst Fund Ix L.P BluelineDirectorBuy7,390$8.32$61,484.80View SEC Filing  
6/3/2014William M MooreCEOBuy5,000$8.48$42,400.00View SEC Filing  
5/21/2014James H MackanessCFOSell3,000$8.73$26,190.00View SEC Filing  
5/19/2014Ronald SteckelVPSell1,650$8.82$14,553.00View SEC Filing  
5/9/2014William M MooreCEOBuy5,000$8.40$42,000.00View SEC Filing  
4/22/2014James H MackanessCFOSell4,000$8.74$34,960.00View SEC Filing  
4/17/2014Ronald SteckelVPSell1,650$8.88$14,652.00View SEC Filing  
3/21/2014James H MackanessCFOSell4,000$9.03$36,120.00View SEC Filing  
3/17/2014Ronald SteckelVPSell1,650$9.07$14,965.50View SEC Filing  
2/18/2014Ronald SteckelVPSell1,650$8.60$14,190.00View SEC Filing  
1/17/2014Ronald SteckelVPSell1,650$10.42$17,193.00View SEC Filing  
12/17/2013Ronald SteckelVPSell1,650$8.56$14,124.00View SEC Filing  
12/2/2013James H MackanessCFOSell10,000$10.52$105,200.00View SEC Filing  
9/6/2013Ruediger Naumann-EtienneDirectorBuy3,600$5.99$21,564.00View SEC Filing  
8/9/2013William M MooreCEOBuy10,000$5.88$58,800.00View SEC Filing  
6/19/2013Eduardo AriasVPSell22,768$5.43$123,630.24View SEC Filing  
6/18/2013James H MackanessCFOSell19,862$4.58$90,967.96View SEC Filing  
6/17/2013Eduardo AriasVPSell4,532$5.39$24,427.48View SEC Filing  
6/14/2013James H MackanessCFOSell10,568$5.38$56,855.84View SEC Filing  
6/13/2013James H MackanessCFOSell1,400$5.30$7,420.00View SEC Filing  
6/11/2013Eduardo AriasVPSell1,000$5.61$5,610.00View SEC Filing  
6/11/2013James H MackanessCFOSell1,200$5.61$6,732.00View SEC Filing  
6/10/2013Eduardo AriasVPSell2,400$5.38$12,912.00View SEC Filing  
6/10/2013James H MackanessCFOSell6,970$5.36$37,359.20View SEC Filing  
6/6/2013William M MooreCEOBuy2,000$5.42$10,840.00View SEC Filing  
5/17/2013Eduardo AriasVPSell10,000$6.30$63,000.00View SEC Filing  
3/8/2013Ruediger Naumann-EtienneDirectorBuy2,400$4.80$11,520.00View SEC Filing  
3/7/2013William M MooreCEOBuy10,000$4.66$46,600.00View SEC Filing  
9/6/2012William M MooreCEOBuy10,000$3.76$37,600.00View SEC Filing  
8/15/2012Catalyst Fund Ix L.P BluelineMajor ShareholderBuy60,900$3.19$194,271.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

IRIDEX (NASDAQ IRIX) News Headlines

Source:
DateHeadline
Global Ophthalmic Laser Market Competitive landscape: IRIDEX CorporationGlobal Ophthalmic Laser Market Competitive landscape: IRIDEX Corporation
www.marketwatch.com - April 26 at 9:27 AM
IRIDEX (IRIX) to Release Earnings on ThursdayIRIDEX (IRIX) to Release Earnings on Thursday
www.americanbankingnews.com - April 26 at 3:48 AM
IRIDEX to Report First Quarter 2018 Financial Results on May 3, 2018IRIDEX to Report First Quarter 2018 Financial Results on May 3, 2018
finance.yahoo.com - April 19 at 4:29 PM
IRIDEX Announces Appointment of Maria Sainz and David Bruce to its Board of DirectorsIRIDEX Announces Appointment of Maria Sainz and David Bruce to its Board of Directors
finance.yahoo.com - April 16 at 4:15 PM
IRIDEX (IRIX) Lifted to Hold at Zacks Investment ResearchIRIDEX (IRIX) Lifted to Hold at Zacks Investment Research
www.americanbankingnews.com - April 7 at 11:36 PM
Contrasting IRIDEX (IRIX) & Cutera (CUTR)Contrasting IRIDEX (IRIX) & Cutera (CUTR)
www.americanbankingnews.com - March 31 at 5:37 AM
Iridex Receives CE Mark for Transilluminated ProbeIridex Receives CE Mark for Transilluminated Probe
finance.yahoo.com - March 20 at 9:53 AM
Edited Transcript of IRIX earnings conference call or presentation 8-Mar-18 10:00pm GMTEdited Transcript of IRIX earnings conference call or presentation 8-Mar-18 10:00pm GMT
finance.yahoo.com - March 18 at 9:36 AM
IRIDEX Co. (IRIX) Insider Romeo R. Dizon Sells 2,806 SharesIRIDEX Co. (IRIX) Insider Romeo R. Dizon Sells 2,806 Shares
www.americanbankingnews.com - March 14 at 8:46 PM
IRIDEX (IRIX) Issues Quarterly  Earnings Results, Misses Expectations By $0.17 EPSIRIDEX (IRIX) Issues Quarterly Earnings Results, Misses Expectations By $0.17 EPS
www.americanbankingnews.com - March 9 at 12:38 AM
IRIDEX Announces 2017 Fourth Quarter and Full Year Financial ResultsIRIDEX Announces 2017 Fourth Quarter and Full Year Financial Results
finance.yahoo.com - March 8 at 5:05 PM
IRIDEX (IRIX) Scheduled to Post Quarterly Earnings on ThursdayIRIDEX (IRIX) Scheduled to Post Quarterly Earnings on Thursday
www.americanbankingnews.com - March 1 at 1:12 AM
Pulse Biosciences (PLSE) versus IRIDEX (IRIX) Financial ReviewPulse Biosciences (PLSE) versus IRIDEX (IRIX) Financial Review
www.americanbankingnews.com - February 28 at 11:12 PM
IRIDEX to Present at the 30th Annual Roth ConferenceIRIDEX to Present at the 30th Annual Roth Conference
finance.yahoo.com - February 27 at 4:52 PM
IRIDEX INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Iridex Corp. To Contact The FirmIRIDEX INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Iridex Corp. To Contact The Firm
finance.yahoo.com - February 27 at 4:52 PM
Analysts Anticipate IRIDEX Co. (IRIX) to Post ($0.25) EPSAnalysts Anticipate IRIDEX Co. (IRIX) to Post ($0.25) EPS
www.americanbankingnews.com - February 27 at 1:36 AM
IRIDEX Issues Voluntary Recall of TruFocus LIO Premiere™ Laser Indirect OphthalmoscopeIRIDEX Issues Voluntary Recall of TruFocus LIO Premiere™ Laser Indirect Ophthalmoscope
finance.yahoo.com - February 23 at 4:44 PM
IRIDEX to Report Fourth Quarter and 2017 Financial Results on March 8, 2018IRIDEX to Report Fourth Quarter and 2017 Financial Results on March 8, 2018
finance.yahoo.com - February 20 at 9:15 AM
Quidel (QDEL) and IRIDEX (IRIX) Critical ComparisonQuidel (QDEL) and IRIDEX (IRIX) Critical Comparison
www.americanbankingnews.com - February 19 at 3:20 AM
Zacks: IRIDEX Co. (IRIX) Receives Consensus Rating of "Strong Buy" from BrokeragesZacks: IRIDEX Co. (IRIX) Receives Consensus Rating of "Strong Buy" from Brokerages
www.americanbankingnews.com - January 23 at 8:22 AM
Head-To-Head Analysis: Mazor Robotics (MZOR) and IRIDEX (IRIX)Head-To-Head Analysis: Mazor Robotics (MZOR) and IRIDEX (IRIX)
www.americanbankingnews.com - January 19 at 5:32 PM
IRIDEX Announces Infringement Lawsuit Against QuantelIRIDEX Announces Infringement Lawsuit Against Quantel
finance.yahoo.com - January 9 at 11:18 AM
Zacks: Brokerages Set $13.00 Target Price for IRIDEX Co. (IRIX)Zacks: Brokerages Set $13.00 Target Price for IRIDEX Co. (IRIX)
www.americanbankingnews.com - January 8 at 5:34 PM
IRIDEX Announces Preliminary Operational and Financial Results for 2017 Fourth Quarter and Full YearIRIDEX Announces Preliminary Operational and Financial Results for 2017 Fourth Quarter and Full Year
finance.yahoo.com - January 8 at 11:00 AM
What Are Analysts Saying About IRIDEX Corporation’s (NASDAQ:IRIX) Future?What Are Analysts Saying About IRIDEX Corporation’s (NASDAQ:IRIX) Future?
finance.yahoo.com - January 6 at 9:16 AM
What You Must Know About IRIDEX Corporation’s (NASDAQ:IRIX) Financial HealthWhat You Must Know About IRIDEX Corporation’s (NASDAQ:IRIX) Financial Health
finance.yahoo.com - December 29 at 10:56 AM
ETFs with exposure to IRIDEX Corp. : December 27, 2017ETFs with exposure to IRIDEX Corp. : December 27, 2017
finance.yahoo.com - December 27 at 1:28 PM
IRIDEX Corp. :IRIX-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017IRIDEX Corp. :IRIX-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017
finance.yahoo.com - December 25 at 4:11 PM
IRIDEX (IRIX) Upgraded at Zacks Investment ResearchIRIDEX (IRIX) Upgraded at Zacks Investment Research
www.americanbankingnews.com - December 21 at 12:14 AM
 IRIDEX Co. (IRIX) Receives Consensus Rating of "Strong Buy" from Analysts IRIDEX Co. (IRIX) Receives Consensus Rating of "Strong Buy" from Analysts
www.americanbankingnews.com - December 16 at 11:30 AM
William M. Moore Acquires 5,000 Shares of IRIDEX Co. (IRIX) StockWilliam M. Moore Acquires 5,000 Shares of IRIDEX Co. (IRIX) Stock
www.americanbankingnews.com - December 15 at 9:44 PM
IRIDEX (IRIX) & Accelerate Diagnostics (AXDX) Head-To-Head ComparisonIRIDEX (IRIX) & Accelerate Diagnostics (AXDX) Head-To-Head Comparison
www.americanbankingnews.com - December 4 at 1:34 AM
Head to Head Review: Digirad (DRAD) & IRIDEX (IRIX)Head to Head Review: Digirad (DRAD) & IRIDEX (IRIX)
www.americanbankingnews.com - November 29 at 9:44 PM
Brokerages Anticipate IRIDEX Corporation (IRIX) to Announce ($0.21) Earnings Per ShareBrokerages Anticipate IRIDEX Corporation (IRIX) to Announce ($0.21) Earnings Per Share
www.americanbankingnews.com - November 28 at 7:56 AM
Critical Analysis: IRIDEX Corporation (IRIX) & Mindray Medical International (MR)Critical Analysis: IRIDEX Corporation (IRIX) & Mindray Medical International (MR)
www.americanbankingnews.com - November 18 at 5:20 PM
Comparing Digirad Corporation (DRAD) and IRIDEX Corporation (IRIX)Comparing Digirad Corporation (DRAD) and IRIDEX Corporation (IRIX)
www.americanbankingnews.com - November 9 at 3:38 AM
IRIDEX Corporation (IRIX) Now Covered by Analysts at Roth CapitalIRIDEX Corporation (IRIX) Now Covered by Analysts at Roth Capital
www.americanbankingnews.com - November 3 at 10:48 AM
Edited Transcript of IRIX earnings conference call or presentation 2-Nov-17 9:00pm GMTEdited Transcript of IRIX earnings conference call or presentation 2-Nov-17 9:00pm GMT
finance.yahoo.com - November 3 at 8:44 AM
ETFs with exposure to IRIDEX Corp. : October 27, 2017ETFs with exposure to IRIDEX Corp. : October 27, 2017
finance.yahoo.com - October 28 at 7:08 AM
IRIDEX to Present at Upcoming Investor ConferencesIRIDEX to Present at Upcoming Investor Conferences
finance.yahoo.com - October 26 at 7:37 PM
IRIDEX Corporation (IRIX) Scheduled to Post Earnings on ThursdayIRIDEX Corporation (IRIX) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - October 26 at 6:10 AM
IRIDEX to Report Third Quarter 2017 Financial Results on November 2, 2017IRIDEX to Report Third Quarter 2017 Financial Results on November 2, 2017
finance.yahoo.com - October 20 at 12:40 AM
ETFs with exposure to IRIDEX Corp. : October 9, 2017ETFs with exposure to IRIDEX Corp. : October 9, 2017
finance.yahoo.com - October 9 at 8:00 PM
IRIDEX Corp. :IRIX-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017IRIDEX Corp. :IRIX-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017
finance.yahoo.com - October 6 at 11:55 PM
Analyzing IRIDEX Corporation (IRIX) and Thermo Fisher Scientific (TMO)Analyzing IRIDEX Corporation (IRIX) and Thermo Fisher Scientific (TMO)
www.americanbankingnews.com - September 30 at 12:26 PM
IRIDEX Corporation (IRIX) Chairman Buys $16,956.00 in StockIRIDEX Corporation (IRIX) Chairman Buys $16,956.00 in Stock
www.americanbankingnews.com - September 18 at 8:32 PM
Analyzing IRIDEX Corporation (IRIX) and Alliance HealthCare Services (AIQ)Analyzing IRIDEX Corporation (IRIX) and Alliance HealthCare Services (AIQ)
www.americanbankingnews.com - September 18 at 12:30 AM
IRIDEX Corporation (IRIX) & Its Rivals Head to Head AnalysisIRIDEX Corporation (IRIX) & Its Rivals Head to Head Analysis
www.americanbankingnews.com - September 17 at 8:30 PM
Is It The Right Time To Buy IRIDEX Corporation (IRIX)?Is It The Right Time To Buy IRIDEX Corporation (IRIX)?
finance.yahoo.com - September 11 at 8:42 PM
Critical Survey: IRIDEX Corporation (IRIX) & The CompetitionCritical Survey: IRIDEX Corporation (IRIX) & The Competition
www.americanbankingnews.com - September 9 at 2:08 PM

SEC Filings

IRIDEX (NASDAQ:IRIX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

IRIDEX (NASDAQ:IRIX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

IRIDEX (NASDAQ IRIX) Stock Chart for Thursday, April, 26, 2018

Loading chart…

This page was last updated on 4/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.